(Q42261396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Synthesis of an (11) C-labeled antiprion GN8 derivative and evaluation of its brain uptake by positron emission tomography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Tsutomu Kimura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Takeo Sako

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Siqin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Junji Hosokawa-Muto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yi Long Cui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yasuhiro Wada

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yosky Kataoka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Suehiro Sakaguchi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Masaaki Suzuki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yasuyoshi Watanabe

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Kazuo Kuwata

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

24 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1035-1039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

2 March 2020

positron emission tomography

1 reference

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

21 January 2018

Prion Protein Biology

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Prion diseases--close to effective therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Recent advances in prion chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Emerging therapeutic agents for transmissible spongiform encephalopathies: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Therapeutic trials in human transmissible spongiform encephalo-pathies: recent advances and problems to address

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Synthesis of 9-substituted 2,3,4,9-tetrahydro-1H-carbazole derivatives and evaluation of their anti-prion activity in TSE-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Hot spots in prion protein for pathogenic conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Regulating the conformation of prion protein through ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Theoretical study of the prion protein based on the fragment molecular orbital method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Pharmacological chaperone for the structured domain of human prion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Using positron emission tomography to facilitate CNS drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Prion infection impairs the cellular response to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

The Palladium-Catalyzed Cross-Coupling Reactions of Organotin Reagents with Organic Electrophiles[New Synthetic Methods(58)]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

A porphyrin increases survival time of mice after intracerebral prion infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Results of quinacrine administration to patients with Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

2-Aminothiazoles as therapeutic leads for prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

Docking Ligands on Protein Surfaces: The Case Study of Prion Protein

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCMDC.201300167

21 January 2018

https://api.crossref.org/works/10.1002%2FCMDC.201300167

7 January 2021

Synthesis of GN8 derivatives and evaluation of their antiprion activity in TSE-infected cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

7 January 2021

Respiratory and cardiovascular toxicity studies of a novel antiprion compound, GN8, in rats and dogs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

7 January 2021

Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300167

7 January 2021

Identifiers

DOI

10.1002/CMDC.201300167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23712919%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference